Advisor Group Holdings, Inc. Adial Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$0.21 - $0.37 $147 - $259	700 Added 3.0%	24,046 $5,000
Q1 2023 May 12, 2023	BUY	$0.24 - $0.56 $3,606 - $8,414	15,025 Added 180.57%	23,346 $8,000
Q1 2021 May 13, 2021	BUY	N/A	3,063 Added 58.25%	8,321 $20,000
Q4 2020 Feb 10, 2021	SELL	N/A	-1,016 Reduced 16.19%	5,258 $9,000
Q2 2020 Aug 14, 2020	SELL	N/A	-1,613 Reduced 20.45%	6,274 $9,000

Q1 2020 May 18, 2020	BUY	N/A	7,887 New	7,887 $10,000

5.5K

Ticker ADIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,854,000
Market Cap $28.2M
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.